Skip to main content
SpringerLink
Log in

Lesions of the Peripheral Nervous System

  • Conference paper
Management in Neuro-Oncology

Part of the book series: ESO Monographs ((ESO MONOGRAPHS))

  • 32 Accesses

Abstract

The identification of peripheral nervous lesions plays at least two important roles in the management of cancer patients: a) by allowing an earlier diagnosis of the underlying neoplasia and thus hastening its therapy, or b) by pointing to new locations of an already known malignancy and thereby determining its extent.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Rereferences

  1. Greenberg HS, Deck MDF, Vikram B et al: Metastasis to the base of the skuli: Clinical findings in 43 patients. Neurology 1981 (31):530–537

    PubMed  CAS  Google Scholar 

  2. Sandler SG, Tobin W, Henderson ES: Vincristine- induced neuropathy. Neurology 1969 (19):367–374

    PubMed  CAS  Google Scholar 

  3. Whitaker JA, Griffith IP: Recurrent laryngeal nerve paralysis in patients receiving vincristine and vinblastine. Br Med J 1977 (1):1251–1252

    Article  Google Scholar 

  4. Massey EW, Moore J and Schold SC: Mental neuropathy from systemic cancer. Neurology 1981 (31):1277–1281

    PubMed  CAS  Google Scholar 

  5. Clouston PD, Sharpe DM, Corbett AJ et al: Perineural spread of cutaneous head and neck cancer. Arch Neurol 1990 (47):73–77

    PubMed  CAS  Google Scholar 

  6. Turgman J, Braham J, Modan B and Goldhammer Y: Neurological complications in patients with malignant tumors of the nasopharynx. Europ Neurol 1978 (17):149–154

    Article  PubMed  CAS  Google Scholar 

  7. Berger PS and Bataini JP: Radiation-induced cranial nerve palsy. Cancer 1977 (40):152–155

    Article  PubMed  CAS  Google Scholar 

  8. Meyer JE and Wang CC: Carcinoma of nasopharynx. Factors influencing results of therapy. Radiology 1971 (100):385–388

    PubMed  CAS  Google Scholar 

  9. Layzer RB: Neoplastic Diseases. In: Neuromuscular Manifestations of Systemic Disease. Davis Co, Philadelphia 1985, pp 258–259

    Google Scholar 

  10. Hepper NGG, Herskovic T, Witten DM et al: Thoracic inlet tumors. Ann Intern Med 1966 (64):979–989

    Google Scholar 

  11. Attar S, Miller JE, Satterfield J et al: Pancoat’s tumor: Irradiation or surgery? Ann Thorac Surg 1979 (28):578–586

    Article  PubMed  CAS  Google Scholar 

  12. Batzdorf U and Brechner VL: Management of pain associated with the Pancoast’ syndrome. Ann J Surg 1979 (137):638–646

    Article  CAS  Google Scholar 

  13. Kori SH, Foley KM, and Posner JB: Brachial plexus lesions in patients with cancer: 100 cases. Neurology 1981 (31):45–50

    PubMed  CAS  Google Scholar 

  14. Cascino TL, Kori S, Krol G, and Foley KM: CT of the brachial plexus in patients with cancer. Neurology 1983 (33):1553–1557

    PubMed  CAS  Google Scholar 

  15. Bagley FH, Walsh JW, Cady B et al: Carcinomatous versus radiation-induced brachial plexus neuropathy in breast cancer. Cancer 1978 (41)2154–2157

    Article  PubMed  CAS  Google Scholar 

  16. Thomas JE, Cascino TL, and Earle JD: Differential diagnosis between radiation and tumor plexopathy of the pelvis. Neurology 1985 (35):1–7

    PubMed  CAS  Google Scholar 

  17. Jaeckle KA, Young DF and Foley KM: The natural history of lumbosacral plexopathy in cancer. Neurology 1985 (35):8–15

    PubMed  CAS  Google Scholar 

  18. Aho I, Sainio K: Late irradiation-induced lesions of the lumbosacral plexus. Neurology 1983 (33):953– 955

    PubMed  CAS  Google Scholar 

  19. Hildebrand J: Peripheral neuropathy. In: Hildebrand J (ed) Neurological Adverse Reactions to Anticancer Drugs. European School of Oncology Mongraph Series. Springer-Verlag, Berlin 1991 pp 93–99

    Google Scholar 

  20. Hildebrand J and Coers C: The neuromuscular function in patients with malignant tumors. Brain 1967 (90):67–82

    Article  PubMed  CAS  Google Scholar 

  21. Krendel DA, Albright RE and Graham DG: Infiltrative polyneuropathy due to acute monoblasts leukemia in hematologic remission. Neurology 1987 (37):474– 477

    PubMed  CAS  Google Scholar 

  22. Roelofs Rl, Hrushesky W, Rogin J, Rosenberg L: Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology 1984 (34):934–938

    PubMed  CAS  Google Scholar 

  23. Lipton RB, Aptel SC, Dutcher JP et al: Taxol produces a predominantly sensory neuropathy. Neurology 1989 (39):368–373

    PubMed  CAS  Google Scholar 

  24. Denny-Brown D: Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiat 1948 (11):73–87

    Article  PubMed  CAS  Google Scholar 

  25. Lisak RP, Mitchell M, Zweiman B et al: Guillain-Baré syndrome and Hodgkin’s disease. Three cases with immunologic studies. Ann Neurol 1977 (1):72–78

    CAS  Google Scholar 

  26. Hildebrand J, Kenis Y: Additive toxicity of vincristine and other drugs for the peripheral nervous system. Acta Neurol Belg 1971 (71):486– 491

    PubMed  CAS  Google Scholar 

  27. Jackson DV, Wells HB, Atkins JN et al: Amelioration of vincristine neurotoxicity by glutamic acid. Ann J Med 1988 (84):1016–1022.

    Article  CAS  Google Scholar 

  28. Favaro G, Di Gregorio F, Panozzo C and Fiori MG: Ganglioside treatment of vincristine-induced neuropathy. An electrophysiologic study. Toxicology 1988, 49: 325–329

    Article  PubMed  CAS  Google Scholar 

  29. Menesini MG, Chen JS, Calissano P and Levi- Montalcini R: Nerve growth factor prevents vinblastine destructive effects on sympathetic ganglia in newborn mice. Proc Natl Acad Sei 1977 (74):5559–5563

    Article  Google Scholar 

  30. Apfel SC, Lipton RB, Arezzo JC and Kessler JA: Nerve growth factor prevents toxic neuropathy in mice. Ann Neurol 1991 (29):87–90

    Article  PubMed  CAS  Google Scholar 

  31. Apfel SC, Arezzo JC, Lipson LA and Kessler JA: Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 1992 (31):76–80

    Article  PubMed  CAS  Google Scholar 

  32. Gerritsen van der Hoop R, Vecht CJ, Van der Burg MEL et al: Prevention of cisplatin neurotoxicity with an ACTH (4–9) analogue in patients with ovarian cancer. N Engl J Med 1990 (322):89–94

    Article  Google Scholar 

  33. Castellanos AM, Glass JP, Yung WKA: Regional nerve injury after intra-arterial chemotherapy. Neurology 1987 (37):834–837

    PubMed  CAS  Google Scholar 

  34. Oh SJ: Diverse electrophysiological spectrum of the Lambert-Eaton myasthenic syndrome. Muscle & Nerve 1989 (12):464–469

    Article  CAS  Google Scholar 

  35. Ongeboer de Visser BW, Boven E, and Ten Bokkel- Huinink WB: Lambert-Eaton syndrome: Electrophysiological normalization during chemotherapy. Clin Neurol Neurosurg 1979 (81):235–240

    Article  Google Scholar 

  36. Jenkyn LR, Brooks PL, Forcier et al: Remission of Lambert-Eaton syndrome and small cell anaplastic carcinoma of the lung induced by chemotherapy and radiotherapy. Cancer 1980 (46):1123–1127

    Article  PubMed  CAS  Google Scholar 

  37. Clamon GH, Evans WK, Sheperd FA et al: Myasthenic syndrome and small cell carcinoma of the lung. Variable response to antineoplastic therapy. Arch Intern Med 1984 (144):999–1000

    CAS  Google Scholar 

  38. O’Neil JH, Murray NMF and Newsom-Davis J: The Lambert-Eaton myasthenic syndrome: a review of 50 cases. Brain 1988 (111): 577–596

    Article  Google Scholar 

  39. Oh SJ and Kim KW: Guanidine hydrochloride in the Lambert-Eaton syndrome. Electrophysiological improvement. Neurology 1973 (23):1084–1090

    Google Scholar 

  40. McEvoy KM, Windeback AJ, Daube JR and Low PA: 3, 4-Diaminopyridine in the treatment of Lambert- Eaton myasthenic syndrome. N Engl J Med 1989 (321):1567–1571

    Article  PubMed  CAS  Google Scholar 

  41. Lundh H, Nilson O and Rosen I: Treatment of Lambert-Eaton syndrome: 3,4-diaminopyridine and pyridostigmine. Neurology 1984 (34):1324–1330

    PubMed  CAS  Google Scholar 

  42. Streib EW and Rothner AD: Eaton-Lambert myasthenic syndrome: Long-term treatment of three patients with prednisolone. Ann Neurol 1981 (0):448–453

    Article  CAS  Google Scholar 

  43. Newson-Davis J and Murray NMF: Plasma exchange and immunodepressive drug treatment in the Lambert-Easton myasthenic syndrome. Neurology 1984 (34):480–485

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Neurologie, Hôpital Erasme, Route de Lennik 808, 1070, Brussels, Belgium

    Jerzy Hildebrand

Authors
  1. Jerzy Hildebrand
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Service de Neurologie Hôpital Erasme, Université Libre de Bruxelles, Route de Lennik, 808, 1070, Bruxelles, Belgium

    Jerzy Hildebrand

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Hildebrand, J. (1992). Lesions of the Peripheral Nervous System. In: Hildebrand, J. (eds) Management in Neuro-Oncology. ESO Monographs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77878-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77878-0_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77880-3

  • Online ISBN: 978-3-642-77878-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation